The influence of pH and fluid dynamics on the antibacterial efficacy of 45S5 Bioglass by Begum, Saima et al.
The influence of pH and fluid dynamics on the antibacterial efficacy of 45S5 Bioglass 
Short title: Antibacterial efficacy of 45S5 Bioglass 
Saima Begum1, William E. Johnson1, Tony Worthington1* and Richard A Martin2* 
1School of Life & Health Science and Aston Research Centre for Healthy Ageing, University of 
Aston, Aston Triangle, Birmingham, B4 7ET, UK. 
2School of Engineering & Applied Science and Aston Research Centre for Healthy Ageing, 
University of Aston, Aston Triangle, Birmingham, B4 7ET, UK. 
*Corresponding authors email R.A.Martin@Aston.ac.uk, T.Worthinton@Aston.ac.uk  
 
In recent years, there has been considerable interest in the potential antibacterial properties that 
bioactive glasses may possess. However, there have been several conflicting reports on the 
antibacterial efficacy of 45S5 Bioglass®. Various mechanisms regarding its mode of action have 
been proposed, such as changes in the environmental pH, increased osmotic pressure, and ‘needle 
like’ sharp glass debris which could potentially damage prokaryotic cell walls and thus inactivate 
bacteria. In this current study, a systematic investigation was undertaken on the antibacterial 
efficacy of 45S5 Bioglass® on Escherichia coli NCTC 10538 and Staphylococcus aureus ATCO 
6538 under a range of clinically relevant scenarios including varying Bioglass® concentration, direct 
and indirect contact between Bioglass® and microorganisms, static and shaking incubation 
conditions, elevated and neutralised pH environments. The results demonstrated that under elevated 
pH conditions, Bioglass® particles has no antibacterial effect on S. aureus whilst, a concentration 
dependent antibacterial effect against E. coli was observed. However, the antibacterial activity 
ceased when the pH of the media was neutralised. The results of this current study therefore suggest 
that the mechanism of antibacterial activity of Bioglass® is associated with changes in the 
environmental pH; an environment that is less likely to occur in vivo due to buffering of the system.  
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Introduction 
Since the discovery of the 45S5 Bioglass®, bioactive glasses (BAGs) have shown great success in 
many clinical applications particularly in the dental and orthopaedic fields [1-3]. 45S5 Bioglass has 
the ability to establish real chemical bonds with both soft (muscle) and hard (bone) tissue [4]. The 
glass is biodegradable and provides a controlled release of calcium and phosphorous ions under 
physiological conditions [1]. These ions then precipitate into amorphous calcium phosphate which 
later crystallise into hydroxyapatite to form new bone mineral [5-7]. In addition to providing the 
fundamental building blocks of bone (Ca and P) the dissolution products of bioglass were also 
found to stimulate osteoblast activity [8, 9]. 
In recent years, there has been considerable interest in the potential antibacterial properties that 
bioactive glasses may possess. However, there have been several conflicting reports on the 
antibacterial efficacy of 45S5 Bioglass. Bioactive glasses (BAGs) have been shown to exhibit an 
antibacterial effect against oral and skin pathogens [10-14]. BAGs have also been shown to reduce 
microbial infections when used as therapeutic materials to treat clinical conditions, such as infected 
frontal sinuses, periodontal defects, and atrophic rhinitis [10]. Based on these results Stoor et al. 
[15] explored the antibacterial properties of BAGs and in 1998 through experiments in vitro, they 
demonstrated that the bioactive glass S53P4 exhibited antibacterial efficacy on oral bacteria when 
cultured in the planktonic phase of growth [10]. Since then several in vitro studies have been 
conducted to determine whether 45S5 Bioglass exerted a similar antibacterial effect on skin 
pathogenic bacteria. Hu et al. [16] showed 45S5 Bioglass to possess broad-spectrum antibacterial 
activity, as it inhibited the growth of all three test microorganisms (Staphylococcus aureus, 
Staphylococcus epidermidis and Escherichia coli).  
Unfortunately, the mechanisms of antibacterial activity are still not clearly understood. Various 
mechanisms regarding its mode of action have been proposed, such as changes in the environmental 
pH, increased osmotic pressure, and ‘needle like’ sharp glass debris which could potentially damage 
prokaryotic cell walls and thus inactivate bacteria [16]. Initial studies on the antibacterial efficacy of 
BAGs revealed that the activity was attributed to the high aqueous pH values caused by the release 
of alkali ions such as, sodium and calcium from BAG particles, when immersed into an aqueous 
environment [11, 17]. It has also been reported that bacterial adhesion on 45S5 particles is a 
necessary step towards bacterial inactivation [16]. On the contrary, Allan et al. [17] has reported 
that direct contact between Bioglass and bacteria is not required to produce an antibacterial effect. 
Studies conducted by Stoor et al. [18] and Bellantone et al. [19] demonstrated that BAGs did not 
possess bacteriostatic or bactericidal activity. These contradictory findings cast doubt on whether 
BAGs are indeed antibacterial in nature. Furthermore it is important to note that different locations 
across an implant site will be subjected to different levels of contact /exposure to bioactive glass as 
illustrated in Figure 1. (a) illustrates a site that is in direct contact and has minimal flow of body 
fluids (represented by direct contact, static tests), (b) illustrates an area which is in direct contact 
with soft tissue and has body fluid buffering the system (represented by direct and indirect contact 
under shaking incubator conditions), and (c) illustrates an area where there is no direct contact and 
only dissolution products are acting on the tissue (represented by the indirect experiments). The 
location and nature of the site will determine the flow of body fluid and buffering of the site and 
therefore sites (b) and (c) have been modelled using pH neutralised and elevated pH experiments. 
Therefore the in vitro experimental conditions required to accurately test for antibacterial activity 
will need to reflect the range of environments that maybe present in vivo. 
The objectives of this current study were to investigate the antibacterial efficacy of 45S5 Bioglass 
particles under a variety of clinically relevant conditions such as direct and indirect contact, the 
effect of the dissolution products, static and shaker incubation conditions and elevated or 
neutralised pH. S. aureus and E. coli were chosen to represent Gram-positive and Gram-negative 
bacteria, respectively. S. aureus has become a major concern regarding prosthetic devices and other 
surgery related-infections. Furthermore Gram-negative bacteria have been recovered from 
biomaterial-related infection sites [20, 21].  
 
Materials and methods 
Glass preparation  
45S5 Bioglass was prepared using CaCO3, SiO2 (both Alfa Aesar, Lancashire, UK), Na2O (Sigma-
Aldrich, Dorset, UK), H6NO4P (Fluka, Dorset UK). The precursors were weighed in molar ratios of 
46.1 SiO2, 26.9 CaO, 24.4 Na2O, and 2.6 % P2O5, thoroughly mixed and placed into a 59 ml volume 
(90% platinum and 10% rhodium) crucible. The crucible was placed into a furnace at room 
temperature and heated at 10ºC/min to 1450ºC and held at this temperature for 90 minutes. Glass 
was cast by pouring the melt into a preheated to (370ºC) graphite mould [6, 22]. The resultant glass 
was ground into particles and sieved (<63 microns). 
 
Microorganisms 
E. coli (NCTC 10538) and S. aureus (ATCO 6538) were used in this study. The microorganisms 
were stored at –70ºC on MicroBank beads (Pro-Lab Diagnostics, Neston, Cheshire, UK) until 
required. Starter cultures for each test microorganism were prepared following inoculation of 
nutrient broth (NB) with a single colony from nutrient agar (NA) plates. After 24 hour incubation at 
37ºC in aerobic conditions, the concentration of microorganism in each starter culture was 
determined by an optical density (OD) (590 nm)/concentration standard curves. The cultures were 
then diluted in NB as required to generate a final working concentration of 106 colony forming unit 
(CFU)/ml.  
 
Investigation of bacterial cell adhesion on 45S5 Bioglass particles by Scanning Electron 
Microscopy (SEM) 
Ten mg of 45S5 Bioglass particles were added to one ml NB and inoculated with the test 
microorganisms at 106 CFU. Glass cover slips inoculated with the test microorganisms served as the 
control. Following a 24 and 96 hour incubation period the samples were fixed with 2.5% 
glutaraldehyde in 0.1% w/v sodium cacodylate buffer (pH 7.4) for 10 minutes, followed by 
dehydration in graded ethanol series. Following the completion of the dehydration step the samples 
were treated with hexamethyldisilazane and left overnight at room temperature and gold-sputtered 
prior to observation with a Carl Zeiss EVO MA10 SEM.  
 
Determination of the antibacterial activity of the 45S5 Bioglass 
Direct contact  
UV sterilised particles of 45S5 Bioglass at 2.5 mg, 5 mg and 10 mg were added to 1 ml NB. 
Bioglass free NB served as the control. Samples were inoculated with the test microorganisms to 
give a final microbial concentration of 106 CFU within the test carrier, incubated at 37ºC under 
aerobic conditions for 24, 48, 72 and 96 hours. Antibacterial properties of 45S5 Bioglass particles 
were evaluated under two different incubation conditions: - static and shaker (100 rpm). At each 
time point the samples were removed, and following a serial dilute 100 µl aliquots were dispensed 
onto NA plates, which were then incubated overnight at 37ºC under aerobic conditions. Following 
incubation, the total viable CFU count was determined, and growth reductions calculated. A 
logarithmic microbial growth reduction of less than 0.5 and 1 are regarded as a slight, values greater 
than 1 and less or equal to 3 as a significant, and values greater than 3 as a strong antibacterial 
activity [23]. 
 
Indirect contact  
Stock solutions were prepared for (UV sterilised) using 45S5 Bioglass particles at 0 (control), 2.5, 5 
and 10 mg/ml in NB. The stock solutions were incubated for 72 hours at 37ºC under aerobic 
conditions in both static and shaker (with a shaking speed of 100 rpm) incubators and then filtered 
using a 0.45 micron syringe filter. One ml was removed from the filtered stock solution and 
inoculated with the test microorganisms at a final concentration of 106 CFU. The inoculated samples 
were incubated at 37ºC under aerobic conditions in both static and shaker (100 rpm) incubators. The 
pH of the stock solution was measured using the Mettler Toledo pH probe. Following 24 and 96 
hours of incubation serial dilutes were performed, and 100 µl aliquots were dispensed onto NA 
plates, which were incubated overnight at 37ºC. Following incubation, the total viable CFU count 
was determined, and growth reductions calculated. 
 
Determination of the antibacterial activity of the 45S5 Bioglass following neutralisation 
Direct contact  
UV sterilised particles of 45S5 Bioglass at 2.5 mg, 5 mg and 10 mg were added to 1 ml NB. NB 
without the 45S5 Bioglass particles served as the control. The samples were incubated overnight at 
37ºC under aerobic conditions in both static and shaker (100 rpm) incubators. After an overnight 
incubation period the samples were removed and the pH recorded. Once the pH was measured the 
samples were neutralised to pH 7.3 (2) to achieve this 0.1M of hydrochloric (HCl) acid was used. 
Neutralised samples were inoculated with the test microorganisms at 106 CFU, incubated overnight 
at 37ºC under aerobic conditions in both static and shaker (100 rpm) incubators. At each time point 
the samples were removed and the pH was measured, and if required the pH was further neutralised 
to 7.3 (2) to ensure the pH remained in the range. Subsequently, serial dilutions were performed, 
followed by 100 µl aliquots being dispensed onto NA plates that were incubated overnight at 37ºC. 
Following incubation total viable CFU count was determined, and growth reductions calculated.  
Indirect contact 
Stock solutions (mg/ml) were prepared for (UV sterilised) 45S5 Bioglass particles at 0 (control), 
2.5, 5 and 10 mg in NB. The stock solutions were incubated for 72 hours at 37ºC under aerobic 
conditions in both static and shaker (with a shaking speed of 100 rpm) incubators. Following the 72 
hour incubation period the stock solutions were filtered using a 0.45 micron syringe filter. One ml 
was removed and neutralised to achieve a pH of 7.3 (2) using 0.1M of HCl and inoculated with the 
test microorganisms at 106 CFU. Remainder of the stock solution was used to measure the pH. The 
samples were incubated at 37ºC under static and shaker (100 rpm) conditions. After 24 and 96 
hours of incubation, the samples were removed, serial dilutions performed and 100 µl aliquots 
dispensed onto NA plates, which were incubated overnight at 37ºC. Following incubation, the total 
viable CFU count was determined, and growth reductions calculated. 
 
Statistical analysis 
Two-way analysis of variance was carried out to determine statistical significances (GraphPad 
Prism). If a significant difference was detected a Tukey test and a Sidak’s test (for the neutralised 
experiments) were carried out to determine which values were significantly different. Differences 
were considered statistically significantly at a level of P < 0.05.  
 
Results 
Bacterial adhesion on 45S5 Bioglass particles 
The SEM images shown in figure 2 demonstrate bacterial adhesion on the surface of 45S5 Bioglass 
particles. S. aureus and E. coli were both able to adhere to 45S5 Bioglass, however a higher level of 
adherence was observed with S. aureus.   
 
Determination of the antibacterial activity of the 45S5 Bioglas  
Direct contact 
Figure 3 shows the antibacterial effect of 45S5 Bioglass particles over a 96 hour period under static 
and shaker incubation conditions. 45S5 Bioglass particles exhibited a strong antibacterial effect 
against E. coli at the concentration of 10 mg/ml. Under shaker incubation conditions 45S5 Bioglass 
particles totally inhibited E. coli growth within 48 hours (< 0.001), with a log reduction of 9.45. 
However, under static conditions the 45S5 Bioglass at 10 mg/ml the particles gradually reduced the 
number of mean viable cells. A log reduction of 7.73 was observed at 96 hours. Also a smaller but 
significant difference was observed for lower concentrations; a 1.87 log reduction was seen for 5 
mg/ml at 96 hours (< 0.0001) under shaking conditions. 45S5 Bioglass particles did not possess a 
strong antibacterial effect against S. aureus.  
 Indirect contact 
Figure 4 shows the antibacterial effect of the dissolution products under static and shaker incubation 
conditions. The dissolution products of 45S5 Bioglass particles showed no antibacterial activity 
against the microorganisms tested under static conditions. However, a strong antibacterial effect 
was demonstrated for E. coli under shaking incubation conditions (10mg/ml), with a log reduction 
of 3.99 at 96 hours (< 0.001). The dissolution products also exhibited a slight antibacterial effect 
against S. aureus with a log reduction of 1 at 96 hours (< 0.05). Table 1 shows the pH values of the 
solutions as a function of 45S5 Bioglass particle concentration. As expected the pH increased with 
increasing concentrations of 45S5 Bioglass particles.  
 
Determination of the antibacterial activity of the 45S5 Bioglass following neutralisation 
Direct contact 
As shown in figure 5 45S5 Bioglass particles showed no antibacterial activity against the test 
microorganisms under both static and shaker incubation conditions once the pH was neutralised. 
 
Indirect contact  
As shown in figure 6 the dissolution products of 45S5 Bioglass particles showed no antibacterial 
effect against E. coli and S. aureus under both static and shaker incubation conditions, following the 
neutralisation of the pH from alkaline to pH 7.3 (2). 
 
Discussion 
In the present study, the results show that particulate 45S5 Bioglass does not possess broad-
spectrum antibacterial properties, as growth inhibition could only be demonstrated for E. coli but 
not for S. aureus. In agreement with the results presented here, Hu et al. [16] reported a significant 
difference between Gram-negative bacterium (E. coli) and Gram-positive bacteria (S. aureus and S. 
epidermidis), when tested against 45S5 Bioglass particles. The difference observed between S. 
aureus and E. coli could be attributed to their cell structures. The cell wall of Gram-positive 
bacteria is primarily composed of a thick peptidoglycan layer however it also contains large 
amounts of teichoic and lipotechoic acids. Doyle et al [24] and Hughes et al [25] demonstrated that 
both the peptidoglycan layer and teichoic acids (which provide highly charged anionic clusters) 
contribute to the binding of metal (such as Na and Ca) ions to the cell wall. This could explain why 
no growth inhibition was seen for S. aureus, as the metal binding sites present in the cell wall 
promoted attachment onto the surface of 45S5 Bioglass particles, evident in the SEM images. 
Furthermore, Stoor et al. [18] discovered that BAGs transiently promote growth and are subject to 
bacterial adhesion due to the presence of Ca ions in the Si-rich layer.  
However, this does not apply to E. coli, which is a Gram-negative bacterium. The cell wall of E. 
coli is composed of a thin peptidoglycan layer with no teichoic acids enclosed within an outer 
membrane. Hu et al. [16] reported that needle like BAG debris was adsorbed onto the surface of E. 
coli, which led to the destruction of the cell wall. In addition, the higher local pH value measured on 
the surface of the 45S5 Bioglass particles, was believed to potentiate the antibacterial effect of 45S5 
Bioglass particles by destructing the bacterial structure.  
Allan et al. [17] found the surface reactions of Bioglass to be capable of killing oral 
microorganisms. The indirect contact experiments were conducted to elucidate whether the 
dissolution products would be sufficient at inducing bacterial cell death, and also if particle 
presence is necessary for bacterial inactivation. BAGs release Na and Ca ions in aqueous 
conditions, and their release elevates the pH. The results for the indirect contact experiments show 
that 45S5 Bioglass particles were only effective at the highest concentration tested (10 mg/ml) at 
reducing E. coli growth under shaking conditions. E. coli has an outer membrane which is 
embedded with pore proteins. The dissolution products released from the 45S5 Bioglass particles 
are small enough to leach into these proteins, and once inside elevate the intracellular pH, resulting 
in cell death. Elevated pH levels of the medium can alter the pH gradient present in the cytoplasmic 
membrane of bacteria, which is important for the movement of nutrients into the cell. Therefore, by 
influencing the transfer and permeability of the cytoplasmic membrane, the high pH can induce 
inhibition and toxic effects on the bacteria [10]. In contrast S. aureus lacks an outer membrane and 
its cell wall binds Ca and Na ions, therefore rendering the dissolution products ineffective. 
Furthermore, Cutinelli and Galdiero [26] demonstrated that an increased pH increased the amount 
of ions bound by S. aureus cell wall. As an increased pH deprotonates functional groups within the 
cell wall, resulting in an increasing number of sites available for metal adsorption [27]. These 
results indicate that the presence of bioactive glass particles play an important role in the 
antibacterial effect along with higher aqueous pH [16]. 
An in vivo study conducted on the antibacterial activity of BAGs revealed that particulate Bioglass 
does not exhibit antibacterial activity in vivo. Xie et al. [10] suggested that the inactivity of 
particulate Bioglass in vivo was due to the ‘big buffer system’ in body fluid, which could swiftly 
exchange dissolution products with nearby blood and other body fluid, so the ionic concentration 
and pH in body fluid at the site of implantation cannot increase to sufficient high levels required to 
inhibit bacterial growth. In this current study the pH was neutralised to represent and recreate a 
physiological environment, from alkaline to 7.3 (2). The results for the neutralised experiments are 
in agreement with the in vivo study. BAGs have a negative surface potential when in aqueous 
solutions and at physiological pH the microorganisms also carry a net negative charge [15]. This 
may explain why no growth inhibition was observed for both E. coli and S. aureus as they were 
potentially unable to bind to the surface of the particles. The release of Ca and Na ions are not 
solely associated with pH elevation but also with osmotic pressure [11, 14, 18]. Allan et al. [17] 
postulated that pH reduction of Bioglass supernates may alter the solubility of particular ions, which 
at higher pH values could be responsible for the antibacterial action. Thus, pH neutralisation of 
45S5 Bioglass particles, may have affected the solubility of Na and Ca ions, preventing an increase 
in the osmotic pressure.  
Furthermore, the incubation conditions influenced the antibacterial effect of 45S5 Bioglass 
particles. 45S5 Bioglass particles significantly inhibited E. coli growth under shaking conditions. 
This could be contributed to the fact that particles under shaking conditions are suspended in 
solution. Therefore, are far more likely to come into contact with the solution resulting in increased 
dissolution, which resulted in higher pH values. Under static conditions, particles on the top layer 
are more likely to be exposed to the solution. However, even under shaking conditions 45S5 
Bioglass particles were unable to exhibit a strong antibacterial effect against S. aureus. This could 
be a result of S. aureus adsorbing onto the surface of the particles, and reducing the dissolution rate.  
 
Conclusion 
A systematic evaluation of the antibacterial effect of 45S5 Bioglass has been undertaken for a range 
of clinically relevant scenarios. 45S5 was found not to possess broad-spectrum antibacterial activity 
as no significant growth inhibition was found for Gram positive S. aureus. Under direct contact 
conditions 45S5 was found to significantly inhibit Gram negative E. coli within 24 hours at the 
highest concentration of 10 mg/ml and partially inhibit growth at 5 mg/ml. An increase in 
antibacterial activity was observed under shaking incubator conditions compared to static 
incubation and 10 mg/ml exhibited a complete kill within 48 hours. For indirect contact the 
dissolution products had negligible antibacterial effect with the exception of 10 mg/ml under 
shaking conditions which exhibited a 4 log reduction. Following neutralisation of the pH 45S5 no 
antibacterial activity was observed for either S. aureus or E. coli even at 10mg/ml under shaking 
incubator conditions. 
The fact that the bacterial cells could withstand the antibacterial effect of the particles following pH 
neutralisation suggests 45S5 Bioglass would not be an effective antibacterial agent in vivo. These 
results highlight the importance of methodology when testing antibacterial properties of 
biodegradable implants. This study illustrates that the antibacterial effect of 45S5 Bioglass particles 
is primarily driven by pH and that contact between ‘needle like’ particles and bacterial cells or 
changes is osmotic pressure have minimal antibacterial efficacy.  
 
Acknowledgements 
The authors would like to thank the Aston Research Centre for Healthy Ageing for funding this 
research. 
References  
[1] Hench LL. The story of Bioglass (R). Journal of Materials Science-Materials in Medicine 2006;17:967-78. 
[2] Hench LL, Day DE, Höland W, Rheinberger VM. Glass and Medicine. International Journal of Applied 
Glass Science 2010;1:104-17. 
[3] Jones JR. Review of bioactive glass: From Hench to hybrids. Acta Biomaterialia 2013;9:4457-86. 
[4] Hench LL, Splinter, R. J., Allen, W. C. and Greenlee, T. K. Bonding mechanisms at the interface of ceramic 
prosthetic materials. Journal of Biomedical Materials Research Symposium 1971;5:25. 
[5] Martin RA, Yue S, Hanna JV, Lee PD, Newport RJ, Smith ME, et al. Characterizing the hierarchical 
structures of bioactive sol-gel silicate glass and hybrid scaffolds for bone regeneration. Philosophical 
Transactions of the Royal Society a-Mathematical Physical and Engineering Sciences 2012;370:1422-43. 
[6] Martin RA, Twyman H, Qiu D, Knowles JC, Newport RJ. A study of the formation of amorphous calcium 
phosphate and hydroxyapatite on melt quenched Bioglass(A (R)) using surface sensitive shallow angle X-ray 
diffraction. Journal of Materials Science-Materials in Medicine 2009;20:883-8. 
[7] FitzGerald V, Martin RA, Jones JR, Qiu D, Wetherall KM, Moss RM, et al. Bioactive glass sol-gel foam 
scaffolds: Evolution of nanoporosity during processing and in situ monitoring of apatite layer formation 
using small- and wide-angle X-ray scattering. Journal of Biomedical Materials Research Part A 2009;91A:76-
83. 
[8] Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts 
following treatment with the ionic products of Bioglass (R) 45S5 dissolution. Journal of Biomedical Materials 
Research 2001;55:151-7. 
[9] Xynos ID, Edgar AJ, Buttery LDK, Hench LL, Polak JM. Ionic products of bioactive glass dissolution 
increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and 
protein synthesis. Biochemical and Biophysical Research Communications 2000;276:461-5. 
[10] Xie ZP, Zhang CQ, Yi CQ, Qiu JJ, Wang JQ, Zhou J. In Vivo Study Effect of Particulate Bioglass (R) in the 
Prevention of Infection in Open Fracture Fixation. Journal of Biomedical Materials Research Part B-Applied 
Biomaterials 2009;90B:195-201. 
[11] Mortazavi V, Nahrkhalaji MM, Fathi MH, Mousavi SB, Esfahani BN. Antibacterial effects of sol-gel-
derived bioactive glass nanoparticle on aerobic bacteria. Journal of Biomedical Materials Research Part A 
2010;94A:160-8. 
[12] Leppaeranta O, Vaahtio M, Peltola T, Zhang D, Hupa L, Hupa M, et al. Antibacterial effect of bioactive 
glasses on clinically important anaerobic bacteria in vitro. Journal of Materials Science-Materials in 
Medicine 2008;19:547-51. 
[13] Zhang D, Lepparanta O, Munukka E, Ylanen H, Viljanen MK, Eerola E, et al. Antibacterial effects and 
dissolution behavior of six bioactive glasses. Journal of Biomedical Materials Research Part A 2010;93A:475-
83. 
[14] Munukka E, Lepparanta O, Korkeamaki M, Vaahtio M, Peltola T, Zhang D, et al. Bactericidal effects of 
bioactive glasses on clinically important aerobic bacteria. Journal of Materials Science-Materials in 
Medicine 2008;19:27-32. 
[15] Stoor P, Soderling E, Salonen JI. Antibacterial effects of a bioactive glass paste on oral microorganisms. 
Acta Odontologica Scandinavica 1998;56:161-5. 
[16] Hu S, Chang J, Liu M, Ning C. Study on antibacterial effect of 45S5 Bioglass(A (R)). Journal of Materials 
Science-Materials in Medicine 2009;20:281-6. 
[17] Allan I, Newman H, Wilson M. Antibacterial activity of particulate Bioglass (R) against supra- and 
subgingival bacteria. Biomaterials 2001;22:1683-7. 
[18] Stoor P, Kirstila V, Soderling E, Kangasniemi I, Herbst K, YliUrpo A. Interactions between bioactive glass 
and periodontal pathogens. Microbial Ecology in Health and Disease 1996;9:109-14. 
[19] Bellantone M, Williams HD, Hench LL. Broad-spectrum bactericidal activity of Ag2O-doped bioactive 
glass. Antimicrobial Agents and Chemotherapy 2002;46:1940-5. 
[20] Hughes SPF. THE ROLE OF ANTIBIOTICS IN PREVENTING INFECTIONS FOLLOWING TOTAL HIP-
REPLACEMENT. Journal of Hospital Infection 1988;11:41-7. 
[21] Naylor PT, Myrvik QN, Gristina A. ANTIBIOTIC-RESISTANCE OF BIOMATERIAL-ADHERENT COAGULASE-
NEGATIVE AND COAGULASE-POSITIVE STAPHYLOCOCCI. Clinical Orthopaedics and Related Research 
1990:126-33. 
[22] Martin RA, Twyman HL, Rees GJ, Smith JM, Barney ER, Smith ME, et al. A structural investigation of the 
alkali metal site distribution within bioactive glass using neutron diffraction and multinuclear solid state 
NMR. Physical Chemistry Chemical Physics 2012;14:12105-13. 
[23] Wiegand C, Abel M, Ruth P, Elsner P, Hipler U-C. In vitro assessment of the antimicrobial activity of 
wound dressings: influence of the test method selected and impact of the pH. Journal of Materials Science-
Materials in Medicine 2015;26. 
[24] Doyle RJ, Matthews TH, Streips UN. CHEMICAL BASIS FOR SELECTIVITY OF METAL-IONS BY THE 
BACILLUS-SUBTILIS CELL-WALL. Journal of Bacteriology 1980;143:471-80. 
[25] Hughes AH, Hancock IC, Baddiley J. FUNCTION OF TEICHOIC ACIDS IN CATION CONTROL IN BACTERIAL 
MEMBRANES. Biochemical Journal 1973;132:83-&. 
[26] Cutinelli C, Galdiero F. Ion-binding properties of the cell wall of Staphylococcus aureus. Journal of 
bacteriology 1967;93:2022-3. 
[27] Fowle DA, Fein JB. Competitive adsorption of metal cations onto two gram positive bacteria: Testing 
the chemical equilibrium model. Geochimica Et Cosmochimica Acta 1999;63:3059-67. 
 
  
  
 
 
 
 
Figure 1 a schematic illustration of the different types of environments present within a bone defect 
filled with bioactive glass particles. 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2 SEM images of S. aureus and E. coli cultured on 45S5 Bioglass particles and glass cover slips (control). E. coli 
cultured on glass cover slips at (a) 24 and (b) 96 hours and on 45S5 Bioglass particles at (c) 24 and (d) 96 hours. S. 
aureus cultured on glass cover slips at (e) 24 and (f) 96 hours, and on 45S5 Bioglass particles at (g) 24 and (h) 96 hours. 
Scale bar represents 2µm.  
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Fig.3  The antibacterial effect of 45S5 Bioglass particles on the viability of E. coli and S. aureus under static (a and b) 
and shaker (c and d) incubation conditions over a 96 hour period. 
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Fig. 4 The antibacterial effect of the dissolution products on the viability of E. coli and S. aureus under static (a and b) 
and shaker (c and d) incubation conditions. 
 
Concentration of  
45S5 Bioglass 
particles (mg/ml)                 
0 2.5 5 10 
Static   7.4 8.70 9.09 9.29 
Shaker  7.4 8.72 9.25 9.70 
Table 1 The aqueous pH values of the 45S5 Bioglass particle suspension for static and shaker incubation conditions.  
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Fig.5 The antibacterial effect of 45S5 Bioglass particles on the viability of E. coli and S. aureus under static (a and b) 
and shaker (c and d) incubation conditions, once the pH was neutralised to pH 7.3 (2).  
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Fig.6  The antibacterial effect of the dissolution products of 45S5 Bioglass particles at a concentration of 10 mg/ml on 
the viability of E. coli and S. aureus under static (a and b) and shaker (c and d) incubation conditions, following the 
neutralisation of the pH from alkaline to pH 7.3 (2). 
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